PubMed ID: 22017839 Author(s): Cordeiro MF, Levin LA. Clinical evidence for neuroprotection in glaucoma. Am J Ophthalmol. 2011 Nov;152(5):715-6. doi: 10.1016/j.ajo.2011.06.015. PMID 22017839 Journal: American Journal Of Ophthalmology, Volume 152, Issue 5, Nov 2011
All Posts
Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2.
PubMed ID: 21862954 Author(s): Aiello LP, Vignati L, Sheetz MJ, Zhi X, Girach A, Davis MD, Wolka AM, Shahri N, Milton RC; PKC-DRS and PKC-DRS2 Study Groups. Oral protein kinase c β inhibition using ruboxistaurin: …
Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.
PubMed ID: 21659941 Author(s): Bhatt SS, Stepien KE, Joshi K. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina. 2011 Nov;31(10):2032-6. doi: 10.1097/IAE.0b013e31820f4b4f. PMID 21659941 Journal: Retina (Philadelphia, Pa.), Volume 31, Issue 10, …
Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine.
PubMed ID: 21839131 Author(s): Jones JC, Settles EW, Brandt CR, Schultz-Cherry S. Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine. Vaccine. 2011 Oct 13;29(44):7696-703. doi: 10.1016/j.vaccine.2011.07.133. Epub 2011 Aug 10. PMID 21839131 …
Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function.
PubMed ID: 21972262 Author(s): Weinreb RN, Kaufman PL. Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function. Invest Ophthalmol …
Modifiable determinants of hearing impairment in adults.
PubMed ID: 21871479 Author(s): Zhan W, Cruickshanks KJ, Klein BE, Klein R, Huang GH, Pankow JS, Gangnon RE, Tweed TS. Modifiable determinants of hearing impairment in adults. Prev Med. 2011 Oct;53(4-5):338-42. doi: 10.1016/j.ypmed.2011.08.012. Epub 2011 …
The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy.
PubMed ID: 21492158 Author(s): Rein DB, Wittenborn JS, Zhang X, Allaire BA, Song MS, Klein R, Saaddine JB; Vision Cost-Effectiveness Study Group. The cost-effectiveness of three screening alternatives for people with diabetes with no or …
Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.
PubMed ID: 21840602 Author(s): Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Louis TA, Sugar EA, Thorne JE. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide …
Photoreceptor structure and function in patients with congenital achromatopsia.
PubMed ID: 21778272 Author(s): Genead MA, Fishman GA, Rha J, Dubis AM, Bonci DM, Dubra A, Stone EM, Neitz M, Carroll J. Photoreceptor structure and function in patients with congenital achromatopsia. Invest Ophthalmol Vis Sci. …